Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charalambos Gogos

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
The Lancet. Infectious Diseases|July 18, 2024
Antiviral therapy for patients with COVID-19: mix and matchKarolina Akinosoglou, Charalambos Gogos
World Journal of Gastroenterology|November 12, 2014
Immune-modulating therapy in acute pancreatitis: fact or fictionKarolina Akinosoglou, Charalambos Gogos
Respirology (Carlton, Vic.)|September 21, 2020
Severe COVID-19 and interleukin-6 receptor antagonist tocilizumab: Some notes of concernKarolina Akinosoglou, Charalambos Gogos
International Journal of Clinical Practice|October 21, 2021
Dexamethasone in COVID-19: Should we consider a "golden hour" practice?Karolina Akinosoglou, Charalambos Gogos
American Journal of Respiratory and Critical Care Medicine|September 12, 2017
Sepsis-3 in Community-acquired Pneumonia: How Reliable Is It?Karolina Akinosoglou, Charalambos Gogos
Viruses|November 27, 2024
Beyond Antivirals: Alternative Therapies for Long COVIDAchilleas Livieratos, Charalambos Gogos, Karolina Akinosoglou
Viruses|July 27, 2024
Macrophage Activation Syndrome in Viral SepsisDespoina Papageorgiou, Charalambos Gogos, Karolina Akinosoglou
Viruses|November 24, 2022
Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/RitonavirKarolina Akinosoglou, Georgios Schinas, Charalambos Gogos
Viruses|August 29, 2024
SARS-CoV-2 Variants and Clinical Outcomes of Special Populations: A Scoping Review of the LiteratureAchilleas Livieratos, Charalambos Gogos, Karolina Akinosoglou
Viruses|May 25, 2024
Impact of Prior COVID-19 Immunization and/or Prior Infection on Immune Responses and Clinical OutcomesAchilleas Livieratos, Charalambos Gogos, Karolina Akinosoglou
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
The Lancet. Infectious Diseases|July 18, 2024
Antiviral therapy for patients with COVID-19: mix and matchKarolina Akinosoglou, Charalambos Gogos
World Journal of Gastroenterology|November 12, 2014
Immune-modulating therapy in acute pancreatitis: fact or fictionKarolina Akinosoglou, Charalambos Gogos
Respirology (Carlton, Vic.)|September 21, 2020
Severe COVID-19 and interleukin-6 receptor antagonist tocilizumab: Some notes of concernKarolina Akinosoglou, Charalambos Gogos
International Journal of Clinical Practice|October 21, 2021
Dexamethasone in COVID-19: Should we consider a "golden hour" practice?Karolina Akinosoglou, Charalambos Gogos
American Journal of Respiratory and Critical Care Medicine|September 12, 2017
Sepsis-3 in Community-acquired Pneumonia: How Reliable Is It?Karolina Akinosoglou, Charalambos Gogos
Viruses|November 27, 2024
Beyond Antivirals: Alternative Therapies for Long COVIDAchilleas Livieratos, Charalambos Gogos, Karolina Akinosoglou
Viruses|July 27, 2024
Macrophage Activation Syndrome in Viral SepsisDespoina Papageorgiou, Charalambos Gogos, Karolina Akinosoglou
Viruses|November 24, 2022
Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/RitonavirKarolina Akinosoglou, Georgios Schinas, Charalambos Gogos
Viruses|August 29, 2024
SARS-CoV-2 Variants and Clinical Outcomes of Special Populations: A Scoping Review of the LiteratureAchilleas Livieratos, Charalambos Gogos, Karolina Akinosoglou
Viruses|May 25, 2024
Impact of Prior COVID-19 Immunization and/or Prior Infection on Immune Responses and Clinical OutcomesAchilleas Livieratos, Charalambos Gogos, Karolina Akinosoglou
Pageof 13